North America Diabetes Devices Market - 2025-2033

January 2026 | 56 pages | ID: NDB8D82055DCEN
DataM Intelligence

US$ 2,499.00 US$ 4,350.00 -43 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
North America Diabetes Devices Market reached US$ 13.76 Billion in 2024 and is expected to reach US$ 28.50 Billion by 2033, growing with a CAGR of 7.50% during the forecast period 2026-2033.

The North America Diabetes Devices Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A North America Diabetes Devices Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Device Type
  • Blood Glucose Monitoring (BGM) Devices*
    • Self-Monitoring Devices
    • Blood Glucose Meters
    • Testing Strips
    • Lancets
    • Continuous Glucose Monitoring Devices
    • Sensors
    • Durables
    • Others
  • Management Devices
    • Insulin Pumps
    • Insulin Pens
    • Insulin Syringes
    • Jet Injectors
  • Others
By Distribution Channel
  • Hospital Pharmacies*
  • Retail Pharmacies
  • Diabetes Clinics/Centers
  • Online Pharmacies
  • Others
This Report Covers:
  • Go-to-market Strategy.
  • Neutral perspective on the market performance.
  • Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
  • Customized regional/country reports as per request and country level analysis.
  • Potential & niche segments and regions exhibiting promising growth covered.
  • Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Research Process:

Both primary and secondary data sources have been used in the global North America Diabetes Devices Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS

3.1. Key Trends and Future Projections
3.2. Snippet by Type
3.3. Snippet by Treatment Type
3.4. Snippet by Form

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Rising Technological Advancements
    4.1.1.2. Rising Prevalence of Diabetes
    4.1.1.3. Collaborations and Licensing Agreements
  4.1.2. Restraints
    4.1.2.1. High Costs of Advanced Devices
    4.1.2.2. Regulatory Challenges
    4.1.2.3. Limited Reimbursement Coverage
  4.1.3. Opportunity
    4.1.3.1. Integration with Digital Health Platforms
    4.1.3.2. Expansion into Emerging Markets
  4.1.4. Impact Analysis

5. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

5.1. Market Leaders and Pioneers
  5.1.1. Emerging Pioneers and Prominent Players
  5.1.2. Established Leaders with the Largest Marketing Brand
  5.1.3. Market Leaders with Established Products
5.2. Latest Developments and Breakthroughs
5.3. North America Regulatory and Reimbursement Landscape
5.4. Porter’s Five Forces Analysis
5.5. Supply Chain Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. Unmet Needs and Gaps
5.9. Recommended Strategies for Market Entry and Expansion
5.10. Pricing Analysis and Price Dynamics

6. DIABETES DEVICES MARKET, BY DEVICE TYPE

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  6.1.2. Market Attractiveness Index, By Device Type
6.2. Blood Glucose Monitoring (BGM) Devices*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  6.2.3. Self-Monitoring Devices
  6.2.4. Blood Glucose Meters
  6.2.5. Testing Strips
  6.2.6. Lancets
  6.2.7. Continuous Glucose Monitoring Devices
  6.2.8. Sensors
  6.2.9. Durables
  6.2.10. Others
6.3. Management Devices
  6.3.1. Insulin Pumps
  6.3.2. Insulin Pens
  6.3.3. Insulin Syringes
  6.3.4. Jet Injectors
  6.3.5. Others
6.4. Others

7. DIABETES DEVICES MARKET, BY DISTRIBUTION CHANNEL

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  7.1.2. Market Attractiveness Index, By Distribution Channel
7.2. Hospital Pharmacies*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Retail Pharmacies
7.4. Diabetes Clinics/Centers
7.5. Online Pharmacies
7.6. Others

8. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

8.1. Competitive Overview and Key Market Players
  8.1.1. Market Share Analysis and Positioning Matrix
  8.1.2. Strategic Partnerships, Mergers & Acquisitions
  8.1.3. Key Developments in Product Portfolios and Innovations
  8.1.4. Company Benchmarking

9. COMPANY PROFILES

9.1. Johnson & Johnson Services, Inc.*
  9.1.1. Company Overview
  9.1.2. Product Portfolio
    9.1.2.1. Product Description
    9.1.2.2. Product Key Performance Indicators (KPIs)
  9.1.3. Financial Overview
  9.1.4. Company Revenue
    9.1.4.1. Geographical Revenue Shares
      9.1.4.1.1. Revenue Forecasts
    9.1.4.2. Key Developments
      9.1.4.2.1. Mergers & Acquisitions
      9.1.4.2.2. Key Product Development Activities
      9.1.4.2.3. Regulatory Approvals, etc.
    9.1.4.3. SWOT Analysis
9.2. Abbott
9.3. Dexcom Inc
9.4. Tandem Diabetes Care, Inc.
9.5. LifeScan IP Holdings, LLC.
9.6. Medtronic
9.7. Insulet Corporation
9.8. F. Hoffmann-La Roche AG
9.9. ACON Laboratories, Inc.
9.10. Novo Nordisk A/S.( LIST NOT EXHAUSTIVE)

10. ASSUMPTIONS AND RESEARCH METHODOLOGY

10.1. Data Collection Methods
10.2. Data Triangulation
10.3. Forecasting Techniques
10.4. Data Verification and Validation

11. APPENDIX

11.1. About Us and Services
11.2. Contact Us
Suggestions for Related Report
• US Diabetes Devices Market (https://www.datamintelligence.com/research-report/us-diabetes-devices-market)
• Asia Pacific Diabetes Devices Market (https://www.datamintelligence.com/research-report/asia-pacific-diabetes-devices-market)
For more medical devices-related reports, please click here (https://www.datamintelligence.com/industry-verticals/medical-devices)


More Publications